Mayaro Virus: Mosquito-Borne Diseases

Mayaro Virus: Mosquito-Borne Diseases

The Mayaro virus (MAYV) is a mosquito-borne alphavirus primarily found in tropical regions of Central and South America and the Caribbean. The virus, first identified in 1954 in Mayaro County, Trinidad, is transmitted through the bite of infected mosquitoes, predominantly Haemagogus species, which inhabit forested areas. Aedes mosquitoes, such as Aedes aegypti and Aedes albopictus, can also transmit the virus, raising concerns about potential urban spread. Infection occurs when a mosquito feeds on a human after biting an infected host, typically non-human primates like monkeys or marmosets, which serve as natural reservoirs in the sylvatic cycle. Human activities in or near forested areas, such as logging or tourism, increase the risk of exposure, while the adaptability of Aedes mosquitoes to urban environments poses a threat of transmission in densely populated areas.

Symptoms of Mayaro virus infection typically appear 1–14 days after a mosquito bite and resemble those of other arboviral diseases, such as chikungunya and dengue. The acute phase, lasting 2–5 days, is characterized by high fever (39–40°C), headache, chills, muscle aches (myalgia), and a maculopapular rash, which appears in about 90% of children and 50% of adults. Severe joint pain (arthralgia), particularly in the wrists, ankles, fingers, and toes, is a hallmark symptom, often debilitating and persisting for weeks or even up to a year in over 50% of cases. Less common symptoms include eye pain, swollen lymph nodes, nausea, vomiting, and, rarely, mild hemorrhagic manifestations like petechiae or gingival bleeding. The similarity of these symptoms to other mosquito-borne illnesses complicates clinical diagnosis, necessitating laboratory tests like RT-PCR for viral RNA or ELISA for IgM/IgG antibodies to confirm infection.

Treatment for Mayaro virus disease is supportive, as no specific antiviral medications or vaccines are currently available. Management focuses on symptom relief through rest, hydration, and over-the-counter analgesics like paracetamol. Non-steroidal anti-inflammatory drugs (NSAIDs) are avoided if dengue is suspected due to bleeding risks. In severe cases, hospitalization may be required for intravenous fluids and pain management. The average cost of treatment varies by region and healthcare system. In Kenya, for example, diagnostic tests, such as blood work and RT-PCR, may range from KES 5,000 to 15,000, while outpatient care, including consultations and medications, typically costs KES 2,000–5,000. Hospitalization for severe cases could escalate costs to KES 20,000–50,000, depending on the duration and supportive care required. These estimates exclude indirect costs, such as lost wages due to prolonged recovery from joint pain.

Recovery from Mayaro virus infection is generally favorable, with most patients experiencing symptom resolution within a few weeks. The acute phase is self-limiting, and fatalities are rare, though chronic arthralgia can persist, impacting quality of life and productivity. Approximately 50% of patients report joint pain lasting 3–12 months, particularly those with elevated inflammatory markers like IL-7 and VEGF. Full recovery is typical, with no evidence of permanent joint damage, but ongoing medical supervision may be needed for chronic symptoms.

Recommendation for Mosquito Pest Control: The absence of specific treatments or vaccines underscores the critical importance of preventing Mayaro virus infection through effective mosquito control. Bestcare Pest Control recommends integrated pest management strategies to reduce mosquito populations and minimize transmission risks. These include eliminating stagnant water sources, such as in buckets or tires, to prevent mosquito breeding, and applying eco-friendly insecticides like 0.5% permethrin to clothing and gear. Regular fogging and larviciding in high-risk areas, combined with community education on using DEET-based repellents and installing window screens, can significantly curb mosquito activity. By partnering with Bestcare Pest Control, households and businesses can protect against Mayaro and other mosquito-borne diseases, ensuring safer environments. Contact Bestcare Pest Control at 0722466091 or visit bestcarepestcontrol.co.ke for professional services.

Citation: Centers for Disease Control and Prevention. (2024). Mayaro: Symptoms, Diagnosis, and Treatment. Retrieved from www.cdc.gov[](https://www.cdc.gov/mayaro-virus/symptoms-diagnosis-treatment/index.html)

Best Fumigation Services and Pest Control

Protected By
Shield Security